NCT01143766

Gabapentin to Improve Patient Tolerance in Endoscopic Retrograde Cholangiopancreatography (ERCP)

Premedication With Single Dose Gabapentin to Improve Patient Tolerance in ERCP: A Double-Blind Randomized Controlled Trial

• Status: Completed
• Phase: N/A
• Study type: Interventional
• Enrollment: 56 (actual)
• Sponsor: Indiana University · Academic / Other
• Sex: All
• Age: 18 Years
• Healthy volunteers: Not accepted

Summary

The standard approach to sedation in endoscopic retrograde cholangiopancreatography (ERCP) involves the use of benzodiazepines and opiates to achieve a moderate depth of sedation. There is data to suggest supplementing this regimen with gabapentin may lead to reduced pain, higher patient satisfaction and lower opiate requirements. The investigators are conducting a clinical trial to study this hypothesis.

Conditions

• Conscious Sedation

Interventions

Type	Name	Description
DRUG	Gabapentin	gabapentin 900mg PO x 1 dose, 1 hour prior to the procedure
OTHER	Standard sedation regimen	Combination opiate and benzodiazepine will be administered to achieve moderate sedation. This is the standard of care.

Timeline

• Start date: 2010-04-01
• Primary completion: 2011-12-01
• Completion: 2011-12-01
• First posted: 2010-06-14
• Last updated: 2023-09-28
• Results posted: 2012-12-05

Locations

1 site across 1 country: United States